Actively Recruiting

Age: 18Years +
All Genders
NCT07275658

Timing and Dose of Fluid Deresuscitation in Critically Ill Patients

Led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated on 2026-01-21

150

Participants Needed

2

Research Sites

71 weeks

Total Duration

On this page

Sponsors

A

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Lead Sponsor

O

OLVG

Collaborating Sponsor

AI-Summary

What this Trial Is About

Fluid deresuscitation is an important intervention in the Intensive Care Unit (ICU). This study aims to find (1) determinants of successful deresuscitation, (2) the optimal rate (dose) of deresuscitation based on these determinants, and (3) differences in metabolic profiles for a more personalized approach of deresuscitation. This study is a multicenter, prospective, observational cohort study in critically ill patients. This study will include ICU patients who have a clinical indication for deresuscitation as set by the treating physician. Clinical, ultrasound and laboratory values will be collected and used for analysis.

CONDITIONS

Official Title

Timing and Dose of Fluid Deresuscitation in Critically Ill Patients

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Admission to one of the participating ICUs;
  • Clinical indication for deresuscitation using diuretics or ultrafiltration as set by the treating physician; first attempt during the ICU stay.
Not Eligible

You will not qualify if you...

  • Age below 18 years old;
  • Major cardiac shunts;
  • Moderate to severe aortic regurgitation;
  • Morbid Obesisty (BMI >40);
  • POCUS impossible or unreliable (i.e. pre-existing interstitial lung disease);
  • PLR or modified form of PLR impossible (i.e. ECMO);
  • Transfer from another ICU;
  • Previous inclusion in this study;
  • Patients who are moribund or facing the end of life;
  • Opt out.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

OLVG

Amsterdam, Netherlands, 1091AC

Actively Recruiting

2

Amsterdam UMC

Amsterdam, Netherlands, 1105AZ

Actively Recruiting

Loading map...

Research Team

K

Krijna Opschoor, MD

CONTACT

S

Santje A.S. Slot, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here